Logo image of RECT

RECTITUDE HOLDINGS LTD (RECT) Stock Fundamental Analysis

USA - NASDAQ:RECT - KYG7445R1011 - Common Stock

3.88 USD
+0.18 (+4.86%)
Last: 10/2/2025, 8:00:02 PM
Fundamental Rating

5

Taking everything into account, RECT scores 5 out of 10 in our fundamental rating. RECT was compared to 84 industry peers in the Commercial Services & Supplies industry. RECT has only an average score on both its financial health and profitability. RECT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

RECT had positive earnings in the past year.
In the past year RECT had a positive cash flow from operations.
RECT Yearly Net Income VS EBIT VS OCF VS FCFRECT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 1M 2M 3M 4M

1.2 Ratios

With an excellent Return On Assets value of 12.41%, RECT belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
The Return On Equity of RECT (21.84%) is better than 88.10% of its industry peers.
With an excellent Return On Invested Capital value of 18.40%, RECT belongs to the best of the industry, outperforming 94.05% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for RECT is significantly above the industry average of 10.57%.
The last Return On Invested Capital (18.40%) for RECT is above the 3 year average (15.57%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.41%
ROE 21.84%
ROIC 18.4%
ROA(3y)9.53%
ROA(5y)N/A
ROE(3y)22.31%
ROE(5y)N/A
ROIC(3y)15.57%
ROIC(5y)N/A
RECT Yearly ROA, ROE, ROICRECT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 10 20 30

1.3 Margins

With an excellent Profit Margin value of 8.83%, RECT belongs to the best of the industry, outperforming 80.95% of the companies in the same industry.
RECT's Profit Margin has declined in the last couple of years.
RECT has a better Operating Margin (11.08%) than 73.81% of its industry peers.
RECT's Operating Margin has declined in the last couple of years.
RECT has a Gross Margin (36.03%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of RECT has grown nicely.
Industry RankSector Rank
OM 11.08%
PM (TTM) 8.83%
GM 36.03%
OM growth 3Y-15.25%
OM growth 5YN/A
PM growth 3Y-9.79%
PM growth 5YN/A
GM growth 3Y4.69%
GM growth 5YN/A
RECT Yearly Profit, Operating, Gross MarginsRECT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 10 20 30

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), RECT is creating value.
Compared to 1 year ago, RECT has less shares outstanding
The debt/assets ratio for RECT has been reduced compared to a year ago.
RECT Yearly Shares OutstandingRECT Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 5M 10M
RECT Yearly Total Debt VS Total AssetsRECT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

RECT has an Altman-Z score of 5.03. This indicates that RECT is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 5.03, RECT is doing good in the industry, outperforming 79.76% of the companies in the same industry.
A Debt/Equity ratio of 0.14 indicates that RECT is not too dependend on debt financing.
RECT has a better Debt to Equity ratio (0.14) than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 5.03
ROIC/WACC2.16
WACC8.53%
RECT Yearly LT Debt VS Equity VS FCFRECT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 5M 10M 15M 20M

2.3 Liquidity

RECT has a Current Ratio of 2.25. This indicates that RECT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.25, RECT is in the better half of the industry, outperforming 73.81% of the companies in the same industry.
A Quick Ratio of 1.62 indicates that RECT should not have too much problems paying its short term obligations.
RECT's Quick ratio of 1.62 is fine compared to the rest of the industry. RECT outperforms 70.24% of its industry peers.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.62
RECT Yearly Current Assets VS Current LiabilitesRECT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

3

3. Growth

3.1 Past

RECT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.78%.
RECT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.77% yearly.
Looking at the last year, RECT shows a quite strong growth in Revenue. The Revenue has grown by 10.15% in the last year.
The Revenue has been growing by 13.68% on average over the past years. This is quite good.
EPS 1Y (TTM)-17.78%
EPS 3Y3.77%
EPS 5YN/A
EPS Q2Q%-14.81%
Revenue 1Y (TTM)10.15%
Revenue growth 3Y13.68%
Revenue growth 5YN/A
Sales Q2Q%9.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RECT Yearly Revenue VS EstimatesRECT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 10M 20M 30M 40M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

RECT is valuated correctly with a Price/Earnings ratio of 13.38.
Based on the Price/Earnings ratio, RECT is valued cheaply inside the industry as 82.14% of the companies are valued more expensively.
RECT is valuated cheaply when we compare the Price/Earnings ratio to 27.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.38
Fwd PE N/A
RECT Price Earnings VS Forward Price EarningsRECT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RECT is valued a bit cheaper than 78.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.98
RECT Per share dataRECT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

RECT has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RECT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RECTITUDE HOLDINGS LTD

NASDAQ:RECT (10/2/2025, 8:00:02 PM)

3.88

+0.18 (+4.86%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)07-31 2025-07-31
Earnings (Next)03-25 2026-03-25
Inst Owners0.36%
Inst Owner ChangeN/A
Ins Owners83.45%
Ins Owner ChangeN/A
Market Cap56.26M
AnalystsN/A
Price TargetN/A
Short Float %0.12%
Short Ratio0.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.38
Fwd PE N/A
P/S 1.17
P/FCF N/A
P/OCF 362.02
P/B 2.9
P/tB 2.9
EV/EBITDA 7.98
EPS(TTM)0.29
EY7.47%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.01
OCFY0.28%
SpS3.31
BVpS1.34
TBVpS1.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.41%
ROE 21.84%
ROCE 21.41%
ROIC 18.4%
ROICexc 23.23%
ROICexgc 23.23%
OM 11.08%
PM (TTM) 8.83%
GM 36.03%
FCFM N/A
ROA(3y)9.53%
ROA(5y)N/A
ROE(3y)22.31%
ROE(5y)N/A
ROIC(3y)15.57%
ROIC(5y)N/A
ROICexc(3y)18.49%
ROICexc(5y)N/A
ROICexgc(3y)18.49%
ROICexgc(5y)N/A
ROCE(3y)18.11%
ROCE(5y)N/A
ROICexcg growth 3Y-21.08%
ROICexcg growth 5YN/A
ROICexc growth 3Y-21.08%
ROICexc growth 5YN/A
OM growth 3Y-15.25%
OM growth 5YN/A
PM growth 3Y-9.79%
PM growth 5YN/A
GM growth 3Y4.69%
GM growth 5YN/A
F-Score5
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA 0.39
Cap/Depr 32.63%
Cap/Sales 1%
Interest Coverage 28.54
Cash Conversion 2.29%
Profit Quality N/A
Current Ratio 2.25
Quick Ratio 1.62
Altman-Z 5.03
F-Score5
WACC8.53%
ROIC/WACC2.16
Cap/Depr(3y)16.41%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.67%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.78%
EPS 3Y3.77%
EPS 5YN/A
EPS Q2Q%-14.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.15%
Revenue growth 3Y13.68%
Revenue growth 5YN/A
Sales Q2Q%9.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.18%
EBIT growth 3Y-3.65%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-110.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-95.24%
OCF growth 3Y-46.74%
OCF growth 5YN/A